Additionally, NK cells present in PDA do not co-express activating receptors, NKG2D and DNAM-1, limiting their survival and proliferation in the extremely hostile and hypoxic PDA tumor microenvironment. The gene discussed is CD226; the disease is Patent ductus arteriosus.